Consensus $480.8M.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GKOS:
- Glaukos reports Q2 EPS (24c), consensus (26c)
- Notable companies reporting after market close
- Glaukos price target raised to $117 from $114 at BTIG
- Glaukos announces E.U. MDR certification for iStent infinite
- Glaukos Positioned for Growth with Innovative Epioxa Therapy and First-Mover Advantage in Keratoconus Treatment